KLF4 and breast carcinoma: Because KLF4 is an essential gene for breast cancer stem cell maintenance and it's decrease leads to decreased proportion of stem/progenitor cells [24], B6H12 treatment may reduce the number of bCSC by down-regulation of KLF4, leading to the observed inhibition of asymmetric cell division.